1
Novartis AG
0 1 2 3 4 5
3.76
2
GSK plc
0 1 2 3 4 5
3.40
3
AstraZeneca plc
0 1 2 3 4 5
3.29
4
Roche Holding AG
0 1 2 3 4 5
2.54
5
Merck & Co, Inc
0 1 2 3 4 5
2.51
6
Pfizer Inc
0 1 2 3 4 5
2.48
7
Sanofi
0 1 2 3 4 5
2.35
8
Boehringer Ingelheim
0 1 2 3 4 5
2.27
9
Bayer AG
0 1 2 3 4 5
2.19
10
Johnson & Johnson
0 1 2 3 4 5
1.93
11
Merck KGaA
0 1 2 3 4 5
1.89
12
Bristol Myers Squibb
0 1 2 3 4 5
1.68
13
Eli Lilly & Co
0 1 2 3 4 5
1.41
13
Gilead Sciences
0 1 2 3 4 5
1.41
15
Daiichi Sankyo Co, Ltd
0 1 2 3 4 5
1.35
16
Eisai Co, Ltd
0 1 2 3 4 5
1.34
17
Novo Nordisk A/S
0 1 2 3 4 5
1.27
18
Takeda Pharmaceutical Co, Ltd
0 1 2 3 4 5
1.17
19
AbbVie Inc
0 1 2 3 4 5
0.70
20
Astellas Pharma Inc
0 1 2 3 4 5
0.22
0 1 2 3 4 5

The ranking above shows the position and score of each company in the 2026 Index (left) and 2024 Index (right). Click on a company's name to go to its full report card.